SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-055659
Filing Date
2023-07-10
Accepted
2023-07-10 08:30:21
Documents
15
Period of Report
2023-07-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181448-8k_180lifesci.htm   iXBRL 8-K 46738
2 FIRST AMENDMENT TO 180 LIFE SCIENCES CORP. 2022 OMNIBUS INCENTIVE PLAN ea181448ex10-1_180lifesci.htm EX-10.1 7958
3 FIRST AMENDED AND RESTATED ea181448ex10-2_180lifesci.htm EX-10.2 119701
  Complete submission text file 0001213900-23-055659.txt   430700

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atnf-20230706.xsd EX-101.SCH 3724
5 XBRL DEFINITION FILE atnf-20230706_def.xml EX-101.DEF 26629
6 XBRL LABEL FILE atnf-20230706_lab.xml EX-101.LAB 36680
7 XBRL PRESENTATION FILE atnf-20230706_pre.xml EX-101.PRE 25253
9 EXTRACTED XBRL INSTANCE DOCUMENT ea181448-8k_180lifesci_htm.xml XML 5568
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 231078290
SIC: 2834 Pharmaceutical Preparations